Technology · Biotechnology R&D expenditure
Algeria's biotechnology R&D expenditure stood at 2 $ in 2026. Despite a strong pharmaceutical tradition and a pool of skilled scientists, the country allocates minimal budgets to biotech. Efforts remain focused on conventional medicine and agriculture, while cutting-edge fields like genetic engineering receive no dedicated funding.
Data for 2026 · unit: $
Position
#151 / 197
Algeria world ranking
Country position on the scale from last to first place for this indicator.
DZ
#151
#197#1
Trend
Change over time
Change in indicator over the available period.
0
1990
1
2000
1
2010
3
2020
2
2025
2
2026
Values — $
Comparison
Top countries by Biotechnology R&D expenditure
Where Algeria stands in the world ranking.
1
CNChina
30 B
1
USUSA
30 B
3
JPJapan
25 B
4
MXMexico
1 B
4
BRBrazil
1 B
6
CACanada
800 M
6
DEGermany
800 M
8
ESSpain
650 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Biotechnology R&D expenditure in Algeria — how much?
Based on 2026 data — 2 $. This is rank #151 out of 197 countries.
What is Algeria's rank by Biotechnology R&D expenditure?
Algeria ranks #151 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in Algeria?
Over the available period the indicator changed from 0 to 2 $.